Conclusion
Major studies designed to improve our understanding of the pathophysiology of TMA have been conducted over recent years. This improved knowledge opens up new perspectives for more targeted treatment. However, until these innovative treatments become available, early diagnosis of these diseases is essential in order to rapidly initiate specific treatment, as the interval between diagnosis and initiation of plasma exchange is a decisive element in the prognosis of TTP. Treatment must not be stopped too early or too rapidly and must take into account the various associated factors, especially the presence of infection.
Chapter PDF
Similar content being viewed by others
Keywords
- Intensive Care Unit
- Human Immunodeficiency Virus
- Plasma Exchange
- Disseminate Intravascular Coagulation
- Hemolytic Uremic Syndrome
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.
References
Coppo P, Adrie C, Azoulay E, et al (2003) Infectious diseases as a trigger in thrombotic microangiopathies in intensive care unit (ICU) patients? Intensive Care Med 29:564–569
Coppo P, Vernant J, Veyradier A, et al (2005) Thrombotic thrombocytopenic purpura and other thrombotic microangiopathy syndromes. EMC-Hématologie 2:14–34
Fujikawa K, Suzuki H, McMullen B, Chung D (2001) Purification of human von Willebrand factor-cleaving protease and its identification as a new member of the metalloproteinase family. Blood 98:1662–1666
Gerritsen HE, Robles R, Lammle B, Furlan M (2001) Partial amino acid sequence of purified von Willebrand factor-cleaving protease. Blood 98:1654–1661
Moake JL (2002) Thrombotic microangiopathies. N Engl J Med 347:589–600
Furlan M, Robles R, Galbusera M, et al (1998) von Willebrand factor-cleaving protease in thrombotic thrombocytopenic purpura and the hemolytic-uremic syndrome. N Engl J Med 339:1578–1584
Levy GG, Nichols WC, Lian EC, et al (2001) Mutations in a member of the ADAMTS gene family cause thrombotic thrombocytopenic purpura. Nature 413:488–494
Remuzzi G, Galbusera M, Noris M, et al (2002) von Willebrand factor cleaving protease (ADAMTS13) is deficient in recurrent and familial thrombotic thrombocytopenic purpura and hemolytic uremic syndrome. Blood 100:778–785
Tsai HM, Lain EC (1998) Antibodies to von Willebrand factor-cleaving protease in acute thrombotic thrombocytopenic purpura. N Engl J Med 339:1585–1594
Veyradier A, Obert B, Houllier A, et al (2001) Specific von Willebrand factor-cleaving protease in thrombotic microangiopathies: a study of 111 cases. Blood 98:1765–1772
Pene F, Vigneau C, Auburtin M, et al (2005) Outcome of severe adult thrombotic microangiopathies in the intensive care unit. Intensive Care Med 31:71–78
Hymes KB, Karpatkin S (1997) Human immunodeficiency virus infection and thrombotic microangiopathy. Semin Hematol 34:117–125
Jeejeebhoy FM, Zaltzman JS (1998) Thrombotic microangiopathy in association with cytomegalovirus infection in a renal transplant patient: a new treatment strategy. Transplantation 65:1645–1648
Miniero R, Nesi F, Vai S, et al (1997) Cryptococcal meningitis following a thrombotic microangiopathy in an unrelated donor bone marrow transplant recipient. Pediatr Hematol Oncol 14:469–474
Moorthy B, Makker SP (1979) Hemolytic-uremic syndrome associated with pneumococcal sepsis. J Pediatr 95:558–559
Riggs SA, Wray NP, Waddell CC, Rossen RD, Gyorkey F (1982) Thrombotic thrombocytopenic purpura complicating Legionnaires’ disease. Arch Intern Med 142:2275–2280
Satoh K, Takahashi H, Nagai K, Shibata A (1988) Thrombotic thrombocytopenic purpura and herpes zoster infection. Ann Intern Med 108:154–155
Schroder S, Spyridopoulos I, Konig J, Jaschonek KG, Luft D, Seif FJ (1995) Thrombotic thrombocytopenic purpura (TTP) associated with a Borrelia burgdorferi infection. Am J Hematol 50:72–73
Shalev O, Karni A, Kornberg A, Brezis M (1981) Thrombotic thrombocytopenic purpura associated with Bacteroides bacteremia. Arch Intern Med 141:692
Toscano V, Bontadini A, Falsone G, et al (1995) Thrombotic thrombocytopenic purpura associated with primary tuberculosis. Infection 23:58–59
Noris M, Remuzzi G (2005) Hemolytic uremic syndrome. J Am Soc Nephrol 16:1035–1050
Rossert J, Fischer E (2001) Insuffisances rénales aiguës d’origine glomérulaire et vasculaire. In: Offenstadt G, Vachon F, Cardinaud JP, et al (eds) Réanimation Médicale. Masson, Paris, pp 1239–1248
Roodhooft AM, McLean RH, Elst E, et al (1990) Recurrent haemolytic uraemic syndrome and acquired hypomorphic variant of the third component of complement. Pediatr Nephrol 4:597–599
Dragon-Durey MA, Fremeaux-Bacchi V, Loirat C, et al (2004) Heterozygous and homozygous factor h deficiencies associated with hemolytic uremic syndrome or membranoproliferative glomerulonephritis: report and genetic analysis of 16 cases. J Am Soc Nephrol 15:787–795
Dragon-Durey MA, Loirat C, Cloarec S, et al (2005) Anti-Factor H autoantibodies associated with atypical hemolytic uremic syndrome. J Am Soc Nephrol 16:555–563
Knobl P, Rintelen C, Kornek G, et al (1997) Plasma exchange for treatment of thrombotic thrombocytopenic purpura in critically ill patients. Intensive Care Med 23:44–50
Tardy B (2001) Purpura thrombotique thrombocytopénique. In: Offenstadt G, Vachon F, Cardinaud JP, et al (eds) Réanimation Médicale. Masson, Paris, pp 1316–1319
Remuzzi G, Ruggenenti P (1995) The hemolytic uremic syndrome. Kidney Int 48:2–19
Sadler JE, Moake JL, Miyata T, George JN (2004) Recent advances in thrombotic thrombocytopenic purpura. Hematology (Am Soc Hematol Educ Program):407–423
Chandler WL, Jelacic S, Boster DR, et al (2002) Prothrombotic coagulation abnormalities preceding the hemolytic-uremic syndrome. N Engl J Med 346:23–32
Bell WR, Braine HG, Ness PM, et al (1991) Improved survival in thrombotic thrombocytopenic purpura-hemolytic uremic syndrome. Clinical experience in 108 patients. N Engl J Med 325:398–403
Lara PN, Jr, Coe TL, Zhou H, et al (1999) Improved survival with plasma exchange in patients with thrombotic thrombocytopenic purpura-hemolytic uremic syndrome. Am J Med 107:573–579
Rock G, Shumak K, Kelton J, et al (1992) Thrombotic thrombocytopenic purpura: outcome in 24 patients with renal impairment treated with plasma exchange. Canadian Apheresis Study Group. Transfusion 32:710–714
Pereira A, Mazzara R, Monteagudo J, et al (1995) Thrombotic thrombocytopenic purpura/hemolytic uremic syndrome: a multivariate analysis of factors predicting the response to plasma exchange. Ann Hematol 70:319–323
Rose M, Eldor A (1987) High incidence of relapses in thrombotic thrombocytopenic purpura. Clinical study of 38 patients. Am J Med 83:437–444
Rock GA, Shumak KH, Buskard NA, et al (1991) Comparison of plasma exchange with plasma infusion in the treatment of thrombotic thrombocytopenic purpura. Canadian Apheresis Study Group. N Engl J Med 325:393–397
Wong CS, Jelacic S, Habeeb RL, et al (2000) The risk of the hemolytic-uremic syndrome after antibiotic treatment of Escherichia coli O157:H7 infections. N Engl J Med 342:1930–1936
Sarode R, Gottschall JL, Aster RH, et al (1997) Thrombotic thrombocytopenic purpura: early and late responders. Am J Hematol 54:102–107
Yomtovian R, Niklinski W, Silver B, Sarode R, Tsai HM (2004) Rituximab for chronic recurring thrombotic thrombocytopenic purpura: a case report and review of the literature. Br J Haematol 124:787–795
Gaddis TG, Guthrie TH, Jr, Drew MJ, et al (1997) Treatment of plasma refractory thrombotic thrombocytopenic purpura with protein A immunoabsorption. Am J Hematol 55:55–58
Bennett CL, Connors JM, Carwile JM, et al (2000) Thrombotic thrombocytopenic purpura associated with clopidogrel. N Engl J Med 342:1773–1777
Bennett CL, Weinberg PD, Rozenberg-Ben-Dror K, et al (1998) Thrombotic thrombocytopenic purpura associated with ticlopidine. A review of 60 cases. Ann Intern Med 128:541–544
Nagaya S, Wada H, Oka K, et al (1995) Hemostatic abnormalities and increased vascular endothelial cell markers in patients with red cell fragmentation syndrome induced by mitomycin C. Am J Hematol 50:237–243
Maslo C, Peraldi MN, Desenclos JC, et al (1997) Thrombotic microangiopathy and cytomegalovirus disease in patients infected with human immunodeficiency virus. Clin Infect Dis 24:350–355
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2006 Springer-Verlag Berlin Heidelberg
About this paper
Cite this paper
Samy Modeliar, S., Monge, M., Slama, M. (2006). Thrombotic Microangiopathy Syndrome in the ICU. In: Vincent, JL. (eds) Yearbook of Intensive Care and Emergency Medicine. Yearbook of Intensive Care and Emergency Medicine, vol 2006. Springer, Berlin, Heidelberg. https://doi.org/10.1007/3-540-33396-7_20
Download citation
DOI: https://doi.org/10.1007/3-540-33396-7_20
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-540-30155-4
Online ISBN: 978-3-540-33396-8
eBook Packages: MedicineMedicine (R0)